Bullish Moving Averages
2
Bearish Moving Averages
14
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
46.80Today’s High
47.5052W low
39.0052W High
122.00Open Price
47.50Prev. Close
43.9900Volume
4263.00Value
199423.14Fundamentals
Market Cap
46.80
Price to Earnings
11.90
Price to Book Value
1.00
Dividend Yield
0.00
PE to Growth
1.30
Op Revenue TTM
71.36
Net Profit TTM
3.95
Cash From Operating Activity
5.58
Return on Equity %
8.76
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
100
Week
100
Month
100
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
47.02
PIVOT
First Resistance
47.26
Second Resistance
47.74
Third Resistance
47.98
First Support
46.54
Second Support
46.30
Third Support
45.82
Relative Strength Index
48.4
Money Flow Index
61.08
MACD
0.91
MACD Signal
0.88
Average True Range
2.39
Average Directional Index
31.85
Rate of Change (21)
8.82
Rate of Change (125)
-49.8
Commodity Channel Index
4.9
Williams %R
-67.1
BETA
1 Month
0.83
3 Month
0.5
1 Year
0.15
3 Year
0.11
PRICE CHANGE ANALYSIS
↓ -6.85%
1 Week
Low
High
46.78
51.22
↑ 6.34%
1 Month
Low
High
42
55.5
↓ -7.97%
3 Months
Low
High
41.52
55.5
↓ -53.84%
6 Months
Low
High
39
122
↓ -36.69%
1 Year
Low
High
39
122
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 10.04 | 7.41 | 10.05 | 16.96 | 22.73 | 12.16 | 8.13 | 6.20 | 7.87 | 10.16 | 10.17 | |
| Operating Expenses Qtr | 9.25 | 6.64 | 9.33 | 16.21 | 21.80 | 11.58 | 7.48 | 5.53 | 7.22 | 9.57 | 9.60 | |
| Operating Profit Qtr | 0.75 | 0.68 | 0.48 | 0.70 | 0.76 | 0.44 | 0.66 | 0.63 | 0.55 | 0.55 | 0.53 | |
| EBIDT Qtr Cr | 0.79 | 0.76 | 0.72 | 0.75 | 0.93 | 0.59 | 0.66 | 0.66 | 0.64 | 0.59 | 0.57 | |
| Depreciation Qtr | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Net Profit Qtr | 0.47 | 0.48 | 0.48 | 0.48 | 0.58 | 0.38 | 0.37 | 0.37 | 0.30 | 0.34 | 0.34 | |
| Basic EPS Qtr | 0.47 | 0.48 | 0.48 | 0.48 | 0.58 | 0.41 | 1.14 | 1.14 | 0.93 | 1.04 | 1.04 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 44.45 | 49.23 | 39.43 | 41.19 | 46.96 | |
| Operating Expenses Annual Cr | 41.43 | 46.39 | 36.97 | 38.68 | 44.74 | |
| Operating Profit Annual | 2.61 | 2.49 | 2.28 | 2.34 | 2.19 | |
| Operating Profit Margin Annual % | 5.87 | 5.06 | 5.77 | 5.68 | 4.67 | |
| Total Expenses Annual Cr | 41.83 | 46.85 | 37.60 | 39.53 | 45.42 | |
| EBIDT Annual Cr | 3.03 | 2.83 | 2.45 | 2.50 | 2.22 | |
| EBIDT Annual margin % | 6.81 | 5.76 | 6.22 | 6.07 | 4.72 | |
| Depreciation | 0.18 | 0.09 | 0.10 | 0.06 | 0.02 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1.90 | 1.70 | 1.31 | 1.19 | 1.12 | |
| Net Profit Annual | 1.90 | 1.70 | 1.31 | 1.19 | 1.12 | |
| Basic EPS Annual | 1.90 | 2.65 | 4.04 | 3.68 | 3.44 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 36.10 | 34.30 | 7.65 | 6.34 | 5.15 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.86 | 1.99 | 5.86 | 4.78 | 8.52 | |
| Total Current Liabilities Annual Cr | 2.48 | 8.09 | 4.21 | 5.30 | 5.50 | |
| Total Capital Plus Liabilities Annual Cr | 39.44 | 44.38 | 17.72 | 16.42 | 19.17 | |
| Fixed Assets Annual | 0.33 | 0.48 | 0.20 | 0.24 | 0.12 | |
| Total Non Current Assets Annual | 17.43 | 10.63 | 5.38 | 4.61 | 3.70 | |
| Total Current Assets Annual | 22.02 | 33.75 | 12.34 | 11.81 | 15.47 | |
| Total Assets Annual | 39.44 | 44.38 | 17.72 | 16.42 | 19.17 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 4.51 | 4.51 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 5.73 | -11.95 | 1.10 | 5.44 | -6.55 | |
| Cash from Investing Activity Annual | -6.65 | -5.02 | -0.80 | -0.94 | -3.68 | |
| Cash from Financing Annual Activity | -1.63 | 20.63 | 0.87 | -4.51 | 9.22 | |
| Net Cash Flow Annual | - | 3.66 | 1.17 | -0.02 | -1.01 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 36.09 | 34.30 | 23.55 | 19.51 | 15.84 | |
| ROE Annual % | 5.25 | 4.97 | 17.14 | 18.84 | 21.73 | |
| ROCE Annual % | 7.70 | 7.56 | 17.38 | 21.92 | 16.03 | |
| Total Debt to Total Equity Annual | 0.03 | 0.07 | 0.81 | 0.76 | 1.66 | |
| EBDIT Annual Margin % | 6.87 | 5.79 | 6.25 | 6.09 | 4.72 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 15.84 | 14.34 | 17.21 | 24.36 | 29.27 | 18.28 | 16.26 | 12.93 | 14.64 | 17.68 | 18.69 | |
| Operating Expenses Qtr | 14.16 | 12.77 | 15.81 | 22.80 | 27.66 | 16.95 | 14.84 | 11.53 | 13.13 | 16.45 | 17.43 | |
| Operating Profit Qtr | 1.54 | 1.48 | 1.32 | 1.48 | 1.36 | 1.11 | 1.42 | 1.36 | 1.34 | 1.14 | 1.22 | |
| EBIDT Qtr Cr | 1.69 | 1.57 | 1.40 | 1.56 | 1.61 | 1.33 | 1.42 | 1.40 | 1.50 | 1.23 | 1.26 | |
| Depreciation Qtr | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | 0.04 | 0.06 | 0.05 | 0.05 | |
| Net Profit Qtr | 1.04 | 1.02 | 0.87 | 1.02 | 1.01 | 0.87 | 0.86 | 0.86 | 0.87 | 0.75 | 0.74 | |
| Basic EPS Qtr | 1.04 | 1.02 | 0.87 | 1.02 | 1.01 | 0.94 | 2.66 | 2.65 | 2.67 | 2.30 | 2.29 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 71.76 | 76.74 | 74.57 | 69.92 | 82.01 | |
| Operating Expenses Annual Cr | 65.54 | 70.97 | 69.26 | 64.97 | 77.61 | |
| Operating Profit Annual | 5.82 | 5.25 | 5.00 | 4.77 | 4.35 | |
| Operating Profit Margin Annual % | 8.11 | 6.85 | 6.71 | 6.82 | 5.30 | |
| Total Expenses Annual Cr | 66.32 | 71.79 | 70.34 | 66.39 | 78.81 | |
| EBIDT Annual Cr | 6.22 | 5.77 | 5.31 | 4.95 | 4.40 | |
| EBIDT Annual margin % | 8.67 | 7.51 | 7.12 | 7.08 | 5.37 | |
| Depreciation | 0.29 | 0.20 | 0.20 | 1.28 | 0.10 | |
| PAT Before ExtraOrdinary Items Annual Cr | 3.95 | 3.61 | 3.10 | 2.58 | 2.36 | |
| Net Profit Annual | 3.95 | 3.61 | 3.10 | 2.58 | 2.36 | |
| Basic EPS Annual | 3.95 | 5.61 | 9.54 | 7.93 | 7.25 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 45.03 | 41.19 | 12.64 | 9.54 | 6.36 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 2.02 | 2.33 | 6.26 | 6.57 | 13.09 | |
| Total Current Liabilities Annual Cr | 8.99 | 15.36 | 13.05 | 14.54 | 16.59 | |
| Total Capital Plus Liabilities Annual Cr | 56.04 | 58.88 | 31.94 | 30.65 | 36.04 | |
| Fixed Assets Annual | 3.52 | 2.57 | 2.36 | 2.35 | 1.68 | |
| Total Non Current Assets Annual | 17.56 | 9.18 | 3.68 | 2.52 | 2.02 | |
| Total Current Assets Annual | 38.48 | 49.70 | 28.26 | 28.12 | 34.02 | |
| Total Assets Annual | 56.04 | 58.88 | 31.94 | 30.65 | 36.04 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 4.51 | 4.51 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 5.58 | -10.10 | 3.85 | 5.82 | -13.82 | |
| Cash from Investing Activity Annual | -8.54 | -5.38 | -1.30 | -0.94 | -3.70 | |
| Cash from Financing Annual Activity | -0.46 | 20.41 | -1.20 | -5.14 | 13.42 | |
| Net Cash Flow Annual | -3.42 | 4.92 | 1.35 | -0.26 | -4.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 45.03 | 41.19 | 38.89 | 29.35 | 19.58 | |
| ROE Annual % | 8.76 | 8.76 | 24.53 | 27.01 | 37.05 | |
| ROCE Annual % | 12.60 | 12.78 | 27.01 | 22.78 | 22.09 | |
| Total Debt to Total Equity Annual | 0.11 | 0.11 | 0.68 | 0.94 | 2.15 | |
| EBDIT Annual Margin % | 8.71 | 7.56 | 7.14 | 7.09 | 5.37 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SAMIR DILIPKUMAR SHAH | 44.33 | 74208980 | 0 | 68.8 |
| DILIPKUMAR BHOGILAL SHAH | 10.74 | 74208981 | 0 | 60.59 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| SAURABH BABUBHAI DESAI | 2.45 | 74208991 |
| LALITA . | 1.5 | 74208992 |
| HUF | 4.12 | 74208984 |
| D D MASTER HUF . | 1.24 | 74208985 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jun 23, 2023 | 0.1 | FINAL | Jun 23, 2023 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 25, 2024 | Audited Results | - |
| May 10, 2024 | Others | (Revised) |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 08, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | - |
| May 29, 2023 | Audited Results & Final Dividend | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Oct 10, 2022 | Others | Inter alia, consider and approve the allotment of Equity Shares of the Company by way of preferential issue to promoters / non promoters. |
| Aug 13, 2022 | Quarterly Results | - |
| May 28, 2022 | Audited Results | - |
| Feb 14, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 14, 2021 | Quarterly Results | - |
| Jun 29, 2021 | Audited Results | - |
| Feb 12, 2021 | Quarterly Results | - |
| Nov 14, 2020 | Quarterly Results | - |
| Sep 15, 2020 | Quarterly Results | - |
| Aug 04, 2020 | Others | - |
| Jun 30, 2020 | Audited Results | - |
| Feb 13, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 29, 2019 | Audited Results | - |
| Feb 25, 2019 | Others | To consider: 1. Acquire the Equity Shares of M/s Azillian Healthcare Private Limited, subject to the approval of members; 2. Acquire assets from M/s Oxford Pharma (related party). |
| Jan 16, 2019 | Quarterly Results & Others | Increase in Authorised Capital. |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 14, 2018 | Unaudited Financial Results | - |
| May 25, 2018 | Audited Results | - |
| Feb 14, 2018 | Quarterly Results | - |
| Nov 14, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 29, 2017 | Audited Results | - |
| Feb 13, 2017 | Quarterly Results | - |
| Nov 12, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
05 Jul 2024
Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Revised Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.
05 Jul 2024
Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2024
29 Jun 2024
Medico Intercontinental Ltd - 539938 - Closure of Trading Window
Closure of Trading Window
14 Jun 2024
Medico Intercontinental Ltd - 539938 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Proceedings for Declaration of results of Postal Ballot passed on June 13, 2024.
14 Jun 2024
Medico Intercontinental Ltd - 539938 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Disclousure of Voting Results of Postal Ballot under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizer Report.
01 Jun 2024
Medico Intercontinental Ltd - 539938 - General Announcement - Change Of Name Of Non-Executive Director Of The Company.
Name of one of the Non-Executive Director has been changed from Mrs. Swati Vikramkumar Shah to Mrs. Swati Jay Shah.
27 May 2024
Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR) - Newspaper Publication
25 May 2024
Medico Intercontinental Ltd - 539938 - Submission Of Related Party Transactions Report For The Half Year Ended 31St March 2024
Submission of Related Party Transactions report for the half year ended 31st March 2024
25 May 2024
Medico Intercontinental Ltd - 539938 - Results - Financial Year Ended 31 March 2024
Results - Financial Year ended 31 March 2024
25 May 2024
Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Pursuant to provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 25, 2024, based on the recommendations of Audit Committee, inter alia, considered and approved agenda as per the attached pdf. The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:30 PM.
